Published in Proc Soc Exp Biol Med on April 01, 1975
Enhancement of renal blood flow by furosemide. J Pharmacol Exp Ther (1968) 1.34
Effects of several saluretic-diuretic agents on renal hemodynamics. J Pharmacol Exp Ther (1966) 1.27
Angiotensin II in arterial and renal venous plasma and renal lymph in the dog. J Clin Invest (1971) 1.15
Specificity of the inhibitory effect of "uremic" serum on p-aminohippurate transport. Proc Soc Exp Biol Med (1968) 1.14
Influence of probenecid and alterations in acid-base balance of the saluretic activity of furosemide. J Pharmacol Exp Ther (1965) 1.13
Lack of correlation between natriuretic activity and inhibition of renal Nak-activated ATPase. Proc Soc Exp Biol Med (1965) 1.13
Renin release: relation to renal sodium load and dissociation from hemodynamic changes. Circ Res (1968) 1.07
Natriuretic effect of furosemide after inhibition of prostaglandin synthetase. J Pharmacol Exp Ther (1976) 1.06
Age-related nephropathy in laboratory rats. FASEB J (1988) 1.01
Effects of asphyxia on cardiac output and organ blood flow in the newborn piglet. Pediatr Res (1978) 0.95
Perinatal renal pharmacology. Annu Rev Pharmacol Toxicol (1979) 0.94
Mechanism of natriuretic action of bradykinin. Am J Physiol (1969) 0.93
Control of renin secretion in the dog. Effects of furosemide on the vascular and macula densa receptors. Circ Res (1975) 0.91
Concomitant dietary exposure to polychlorinated biphenyls and polybrominated biphenyls: tissue distribution and arylhydrocarbon hydroxylase activity in lactating rats. Toxicol Appl Pharmacol (1979) 0.90
Cisplatin nephrotoxicity: role of filtration and tubular transport of cisplatin in isolated perfused kidneys. Toxicology (1987) 0.90
Enzymes of renal origin in urine as indicators of nephrotoxicity. Toxicol Appl Pharmacol (1977) 0.90
Renin secretion by rat kidney slices in vitro. Proc Soc Exp Biol Med (1974) 0.89
Effects of environmental chemicals on kidney metabolism and function. Kidney Int (1980) 0.88
Age-related differences in susceptibility to renal ischemia in rats. Toxicol Appl Pharmacol (1987) 0.88
Development of angiotensin-converting enzyme in fetal rat lungs. Am J Physiol (1979) 0.87
Effect of monocrotaline ingestion on liver, kidney, and lung of rats. Toxicol Appl Pharmacol (1981) 0.87
Metabolism and pharmacokinetics of acetaminophen in a severely poisoned young child. J Pediatr (1984) 0.87
Transluminal arterial dilation of a postsurgical stenosis of renal artery implant in a child with recurrent hypertension. Pediatrics (1982) 0.86
Role of the renin-angiotensin system in hypertension after coarctation of the aorta. J Lab Clin Med (1984) 0.86
Carcinogenicity study of auranofin, an orally administered gold compound, in mice. Fundam Appl Toxicol (1988) 0.85
cis-Dichlorodiammineplatinum nephrotoxicity: time course and dose response of renal functional impairment. Toxicol Appl Pharmacol (1981) 0.85
The effect of vasodilator drugs on the noradrenaline constrictor response in the isolated mesenteric artery. Can J Physiol Pharmacol (1969) 0.85
Angiotensin-converting enzyme in developing lung and kidney. Am J Physiol (1978) 0.85
A positive correlation between natriuresis and inhibition of renal Na-K adenosine triphosphatase by ouabain. Proc Soc Exp Biol Med (1969) 0.85
Nephrotoxicity of hexachloro-1,3-butadiene in the mouse: the effect of age, sex, strain, monooxygenase modifiers, and the role of glutathione. Toxicol Appl Pharmacol (1984) 0.84
Intrarenal secretion of renin in the dog: effect of furosemide. Am J Physiol (1973) 0.84
Mechanism of renal handling of angiotensin II in the dog. Circ Res (1973) 0.84
Depletion by 1,2-dibromoethane, 1,2-dibromo-3-chloropropane, tris(2,3-dibromopropyl)phosphate, and hexachloro-1,3-butadiene of reduced non-protein sulfhydryl groups in target and non-target organs. Biochem Pharmacol (1981) 0.84
Nephrotoxicity of paraquat in mice. Toxicol Appl Pharmacol (1975) 0.83
Cardiac glycoside sensitivity of (Na + +K + )-activated ATPase in new-born rats. Res Commun Chem Pathol Pharmacol (1972) 0.83
Effects of aminoglycosides on glomerular permeability, tubular reabsorption, and intracellular catabolism of the cationic low-molecular-weight protein lysozyme. Toxicol Appl Pharmacol (1983) 0.83
In vitro metabolism of C-14-labeled amino acids by sheep kidney cortex and medulla. Am J Physiol (1966) 0.83
Release of vasoactive materials from the kidney by diuretics. J Clin Pharmacol (1977) 0.82
Nephrotoxicity of Hexachloro-1:3-butadiene in the rat: the effect of age, sex, and strain. Toxicol Appl Pharmacol (1983) 0.82
Postnatal development of the renin-angiotensin system in rats. Am J Physiol (1980) 0.82
Renal ultrastructural and biochemical injuries induced by aminoglycosides. Environ Health Perspect (1984) 0.82
Effect of furosemide on renal hilar lymph flow. Arch Int Pharmacodyn Ther (1976) 0.82
Effect of 2,3,7,8-tetrachlorodibenzo-rho-dioxin on renal function in the rat. J Toxicol Environ Health (1976) 0.81
Effects of gentamicin on renal function in isolated perfused kidneys from male and female rats. Toxicol Lett (1985) 0.81
Mechanism of prostaglandin E(2) stimulation of renin secretion. Proc Soc Exp Biol Med (1978) 0.80
Nephrotoxicity of chloroform: metabolism to phosgene by the mouse kidney. Toxicol Appl Pharmacol (1984) 0.80
Metabolism and excretion of a glutathione conjugate of acetaminophen in the isolated perfused rat kidney. J Pharmacol Exp Ther (1986) 0.80
Potentiation of hepatic and renal toxicity of various compounds by prior exposure to polybrominated biphenyls. Environ Health Perspect (1978) 0.80
Effects of polybrominated biphenyls on kidney function and activity of renal microsomal enzymes. Environ Health Perspect (1978) 0.80
Mechanism of chloroform nephrotoxicity. II. In vitro evidence for renal metabolism of chloroform in mice. Toxicol Appl Pharmacol (1983) 0.80
Role of hemodynamic changes in the effect of furosemide on the renal concentrating mechanism. Eur J Pharmacol (1970) 0.80
Developmental aspects of renal pharmacology. Pharmacol Ther (1982) 0.80
Effects of age and sex on hexachloro-1,3-butadiene toxicity in the Fischer 344 rat. Life Sci (1983) 0.80
Acetaminophen nephrotoxicity in the rat. II. Strain differences in nephrotoxicity and metabolism of p-aminophenol, a metabolite of acetaminophen. Toxicol Appl Pharmacol (1983) 0.80
Urinary excretion of renin in the dog: effect of changes in plasma renin. J Pharmacol Exp Ther (1983) 0.80
Analysis of gentamicin uptake by rat renal cortical slices. Toxicol Appl Pharmacol (1978) 0.80
Differential destruction of cytochrome P-450-dependent monooxygenases in rat and mouse kidney following hexachloro-1:3-butadiene administration. Mol Pharmacol (1983) 0.80
Effects of polybrominated biphenyls on metabolism of testosterone by rat hepatic microsomes. Toxicol Appl Pharmacol (1982) 0.79
Glutathione S-transferases: an evaluation of their role in renal organic anion transport. J Pharmacol Exp Ther (1977) 0.79
Acetaminophen nephrotoxicity in the rat. I. Strain differences in nephrotoxicity and metabolism. Toxicol Appl Pharmacol (1983) 0.79
Hepatic and renal conjugation (Phase II) enzyme activities in young adult, middle-aged, and senescent male Sprague-Dawley rats. Proc Soc Exp Biol Med (1991) 0.79
Lipid peroxidation: a possible mechanism of cephaloridine-induced nephrotoxicity. Toxicol Appl Pharmacol (1983) 0.79
Role of alterations in renal hemodynamics in the natriuretic action of glucagon. Arch Int Pharmacodyn Ther (1970) 0.79
The effects of cisplatin and other divalent platinum compounds on glucose metabolism and pancreatic endocrine function. Toxicol Appl Pharmacol (1983) 0.79
Evaluation of a screening tool for inflammatory joint disease. Ann Rheum Dis (2003) 0.79
Gentamicin-induced renal metabolic alterations in newborn rat kidney: lack of potentiation by vancomycin. Toxicol Appl Pharmacol (1989) 0.79
Effect of inhibition of peptidase activity on distribution of intrarenal blood flow. Am J Physiol (1975) 0.79
Postnatal development of renal and hepatic drug-metabolizing enzymes in male and female Fischer 344 rats. Life Sci (1981) 0.79
Nephrotoxicity and hepatotoxicity of chloroform in mice: effect of deuterium substitution. J Toxicol Environ Health (1982) 0.79
Maturation of renal organic acid transport: substrate stimulation by penicillin. Science (1969) 0.79
Paraquat concentration and renal function in mice fed purified and cereal-based diets. Drug Nutr Interact (1983) 0.79
Effect of tolmetin on renal function and prostaglandin metabolism. J Pharmacol Exp Ther (1978) 0.79
Metabolic activation of nephrotoxic haloalkanes. Fed Proc (1980) 0.79
Action of exogenously administered steroid hormones following perinatal exposure to polybrominated biphenyls. J Toxicol Environ Health (1979) 0.79
Functional maturation of renal PAH transport in the dog. Can J Physiol Pharmacol (1970) 0.79
Mechanism of chloroform nephrotoxicity. III. Renal and hepatic microsomal metabolism of chloroform in mice. Toxicol Appl Pharmacol (1984) 0.79
Nephrotoxicity of p-aminophenol, a metabolite of acetaminophen, in the fischer 344 rat. Toxicol Appl Pharmacol (1982) 0.79
Fluoride and methoxyflurane nephropathy. Anesthesiology (1971) 0.78
Effect of anesthesia on cardiovascular and renal function in the newborn piglet. J Pharmacol Exp Ther (1979) 0.78
The renal handling of 2,4,5-trichlorophenoxy- acetic acid (2,4,5-T) in the dog. Food Cosmet Toxicol (1976) 0.78
Glucose intolerance following cis-platinum treatment in rats. Toxicology (1982) 0.78
Renal protein degradation: a biochemical target of specific nephrotoxicants. Fundam Appl Toxicol (1983) 0.78
Effects of asphyxia on renal function in the newborn piglet. Pediatr Res (1978) 0.78
Biochemical and physiological sequelae to perinatal exposure to polybrominated biphenyls: a multigeneration study in rats. Toxicol Appl Pharmacol (1981) 0.78
Chemically induced nephrotoxicity: role of metabolic activation. Crit Rev Toxicol (1984) 0.78
Maturation of renal organic acid transport: substrate stimulation by penicillin and p-aminohippurate (PAH). J Pharmacol Exp Ther (1970) 0.78
Renal tubular transport of saccharin. J Pharmacol Exp Ther (1978) 0.78